Live Webinar

Access, Affordability, & Accountability: A New Era in Oncology Reimbursement

Hosted by AJMC and Targeted Oncology

-- Days : -- HRS : -- MIN : -- SEC
Register Now →
Logo Image
|Articles|May 1, 1999

The American Journal of Managed Care

  • May 1999
  • Volume 5
  • Issue 5

Overview of Platelet Glycoprotein IIb/IIIa Receptor Antagonist Treatment in the Management of Coronary Interventions and Acute Ischemic Coronary Syndromes

Download PDF: Overview of Platelet Glycoprotein IIb/IIIa Receptor Antagonist Treatment in the Management of Coronary Interventions and Acute Ischemic Coronary Syndromes

Articles in this issue

about 27 years ago

Relationship between Primary Payer and Use of Proactive Immunization Practices: A National Survey

about 27 years ago

Polypharmacy Management in Medicare Managed Care: Changes in Prescribing by Primary Care Physicians Resulting from a Program Promoting Medication Reviews

about 27 years ago

Course and Cost of Treatment for Depression with Fluoxetine, Paroxetine, and Sertraline

about 27 years ago

Project LEAP of New Jersey: Lower Extremity Amputation Prevention in Persons with Type 2 Diabetes

about 27 years ago

Quality of Care for Chronic Illness in Primary Care: Opportunities for Improvement in Process and Outcome Measures

about 27 years ago

Assessment of Patient Satisfaction with a Formulary Switch from Omeprazole to Lansoprazole in Gastroesophageal Reflux Disease Maintenance Therapy

about 27 years ago

Benign Prostatic Hyperplasia: An Overview for Pharmacists

about 27 years ago

Correspondence regarding, "How Should Managed Care Treat Onychomycosis?"

Related Content